ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Horizon Therapeutics plc Named a Top Company for Executive Women

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has been recognized by Seramount (formerly Working Mother media) as a Top 75 Company for Executive Women.

Seramount’s list focuses on women in the corporate officer and profit-and-loss leadership ranks. It tracks and examines how many employees have access to programs and policies that promote advancement of women and how many female employees take advantage of them, as well as how companies train managers to help women advance.

“We have purposefully built a workplace where diversity, learning and career growth opportunities for everyone are our standard, not the exception,” said Tim Walbert, chairman, president and chief executive officer, Horizon. “We are honored to be recognized by Seramount for our focus on mentoring, programming and development opportunities for women, which are based in our values and support our aspiration to be a pre-eminent career destination.”

Horizon’s efforts to develop, support and promote women include its commitment to pay equity. Analyses conducted by an external consultant in 2019 and 2021 showed that across all genders and ethnicities, employees receive equal pay for equal work. The company offers a variety of internal career development programs and external mentoring co-ops. Horizon also provides benefits including 16 to 18 weeks of full paid time off to birth mothers (with other parents receiving 10 weeks) as well as subsidized on-site child care at the U.S. headquarters in Deerfield, Ill., and a “Make It Personal” account allowance that can be used for child-care needs.

About Horizon

Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

About Seramount

Seramount, now part of EAB, is a strategic professional services and research firm dedicated to advancing diversity, equity, and inclusion in the workplace. Over four decades, partnering with over 450 of the most iconic companies in the world, we’ve built a deep, data-driven understanding of the employee experience, which lays the groundwork for everything we do. We meet each client’s needs no matter where they are on their journey and guide them along an ever-changing talent landscape. Learn more at www.seramount.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.